Company: OMQS
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001813
Chunk: 80

Company: OMNIQ Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 2
Chunk 80
---
 future determination to pay cash dividends will
be at the discretion of OMNIQ’s Board of Directors. The Company’s Series C Preferred Stock pays a 6% dividend, but the Company
has been unable to make such dividend payments, thus those dividends are accrued quarterly. Accrued but unpaid dividends do not bear
interest.

Recent
Sales of Unregistered Securities

In
December 2015, our Board of Directors approved the OMNIQ’s Employee Stock Purchase Plan (the “ESPP”). During 2024, the Company issued an aggregate of 37,128 shares of common
stock to certain individuals as part of the ESPP valued at approximately $12,064. During 2023,
the Company issued an aggregate of 14,838 shares of common stock to certain individuals as part of the ESPP valued at approximately $31
thousand. This plan was cancelled in 2024.

Issuer
Purchases of Equity Securities

The
Company did not repurchase any of its equity securities during the year ended December 31, 2024.

Use
of Proceeds from Sale of Registered Securities 

On
October 5, 2023, OmniQ Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”)
with ThinkEquity LLC, as representatives (the “Representatives”) of the several underwriters named therein (collectively,
the “Underwriters”), relating to the issuance and sale (the “Offering”) of 2,775,000 shares of the Company’s
common stock, par value $0.001 per share, at a price to the public of $1.00 per share (the “Underwritten Shares”) and pre-funded
warrants (the “Pre-Funded Warrants”) to purchase 225,000 shares of the Company’s common stock at a price to the public
of $0.999 per Pre-Funded Warrant. Under the terms of the Underwriting Agreement, the Underwriters have agreed to purchase the Underwritten
Shares from the Company at a price of $1.00 per share and the Pre-Funded Warrants at a price of $0.999 per Pre-Funded Warrant. The Company
also granted the Underwriters an option exercisable for 45 days from the date of the Underwriting Agreement to purchase up to an additional
450,000 shares of common stock solely for the purpose of covering over-allotments (together with the Underwritten Shares, the “Shares”